Expression and characterization of genetically engineered human immunodeficiency virus-like particles containing modified envelope glycoproteins: implications for development of a cross-protective AIDS vaccine

Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of Virology 1992-07, Vol.66 (7), p.4003-4012
Hauptverfasser:	ROVINSKI, B, HAYNES, J. R, SHI XIAN CAO, JAMES, O, SIA, C, ZOLLA-PAZNER, S, MATTHEWS, T. J, KLEIN, M. H
Format:	Artikel
Sprache:	eng
Schlagworte:	AIDS Vaccines - genetics AIDS Vaccines - immunology AIDS/HIV Amino Acid Sequence Animals Biological and medical sciences CD4 Antigens - metabolism Cell Line Cross Reactions Female Fundamental and applied biological sciences. Psychology Genetic Engineering Genetic Vectors Guinea Pigs HIV Antibodies - biosynthesis HIV Antibodies - immunology HIV Envelope Protein gp120 - genetics HIV Envelope Protein gp120 - immunology HIV Envelope Protein gp120 - metabolism HIV-1 - genetics HIV-1 - immunology human immunodeficiency virus 1 Immunoblotting Mice Microbiology Molecular Sequence Data Neutralization Tests Peptide Fragments - genetics Peptide Fragments - immunology Peptide Fragments - metabolism Plasmids Recombinant Fusion Proteins - genetics Recombinant Fusion Proteins - immunology Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies Vero Cells Virology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!